136 related articles for article (PubMed ID: 21349912)
41. Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer.
Campayo M; Navarro A; Viñolas N; Diaz T; Tejero R; Gimferrer JM; Molins L; Cabanas ML; Ramirez J; Monzo M; Marrades R
Eur Respir J; 2013 May; 41(5):1172-8. PubMed ID: 22835608
[TBL] [Abstract][Full Text] [Related]
42. Verification of wild-type EGFR status in non-small cell lung carcinomas using a mutant-enriched PCR on selected cases.
Chen YL; Lu CC; Yang SC; Su WP; Lin YL; Chen WL; Huang W; Su WC; Chow NH; Ho CL
J Mol Diagn; 2014 Sep; 16(5):486-494. PubMed ID: 25051378
[TBL] [Abstract][Full Text] [Related]
43. EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.
Han B; Tjulandin S; Hagiwara K; Normanno N; Wulandari L; Laktionov K; Hudoyo A; He Y; Zhang YP; Wang MZ; Liu CY; Ratcliffe M; McCormack R; Reck M
Lung Cancer; 2017 Nov; 113():37-44. PubMed ID: 29110846
[TBL] [Abstract][Full Text] [Related]
44. Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.
Jin Y; Chen M; Yu X
Sci Rep; 2016 Aug; 6():31636. PubMed ID: 27527915
[TBL] [Abstract][Full Text] [Related]
45. Visual DNA microarray for detection of epidermal growth factor receptor (EGFR) gene mutations.
Xue L; Fei JJ; Song Y; Xu RH; Bai YJ
Scand J Clin Lab Invest; 2014 Nov; 74(8):693-9. PubMed ID: 25223598
[TBL] [Abstract][Full Text] [Related]
46. A pilot study identifying a potential plasma biomarker for determining EGFR mutations in exons 19 or 21 in lung cancer patients.
Pamungkas AD; Medriano CA; Sim E; Lee S; Park YH
Mol Med Rep; 2017 Jun; 15(6):4155-4161. PubMed ID: 28487968
[TBL] [Abstract][Full Text] [Related]
47. EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study.
Malapelle U; de Luca C; Vigliar E; Ambrosio F; Rocco D; Pisapia P; Bellevicine C; Troncone G
J Clin Pathol; 2016 May; 69(5):454-7. PubMed ID: 26893402
[TBL] [Abstract][Full Text] [Related]
48. Detection of EGFR mutation in supernatant, cell pellets of pleural effusion and tumor tissues from non-small cell lung cancer patients by high resolution melting analysis and sequencing.
Lin J; Gu Y; Du R; Deng M; Lu Y; Ding Y
Int J Clin Exp Pathol; 2014; 7(12):8813-22. PubMed ID: 25674250
[TBL] [Abstract][Full Text] [Related]
49. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
De Luca C; Rappa AG; Gragnano G; Malapelle U; Troncone G; Barberis M
J Clin Pathol; 2018 Aug; 71(8):745-750. PubMed ID: 29798838
[TBL] [Abstract][Full Text] [Related]
50. Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.
Deans ZC; Bilbe N; O'Sullivan B; Lazarou LP; de Castro DG; Parry S; Dodson A; Taniere P; Clark C; Butler R
J Clin Pathol; 2013 Apr; 66(4):319-25. PubMed ID: 23378269
[TBL] [Abstract][Full Text] [Related]
51. Accuracy of the cobas EGFR Mutation Assay in Non-small-cell Lung Cancer Compared With Three Laboratory-developed Tests.
Nakamura H; Koizumi H; Sakai H; Kimura H; Miyazawa T; Marushima H; Saji H; Takagi M
Clin Lung Cancer; 2018 Mar; 19(2):170-174. PubMed ID: 29150249
[TBL] [Abstract][Full Text] [Related]
52. [The detection by denaturing high performance liquid chromatography of epidermal growth factor receptor mutation in tissue and peripheral blood from patients with advanced non-small cell lung cancer].
Bai H; Zhao J; Wang SH; An TT; Wang X; Wu MN; Duan JC; Yang L; Guo QZ; Liu NH; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):891-6. PubMed ID: 19134404
[TBL] [Abstract][Full Text] [Related]
53. Genotype analysis of the NRF2 gene mutation in lung cancer.
Sasaki H; Suzuki A; Shitara M; Hikosaka Y; Okuda K; Moriyama S; Yano M; Fujii Y
Int J Mol Med; 2013 May; 31(5):1135-8. PubMed ID: 23545629
[TBL] [Abstract][Full Text] [Related]
54. Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.
Rachiglio AM; Esposito Abate R; Sacco A; Pasquale R; Fenizia F; Lambiase M; Morabito A; Montanino A; Rocco G; Romano C; Nappi A; Iaffaioli RV; Tatangelo F; Botti G; Ciardiello F; Maiello MR; De Luca A; Normanno N
Oncotarget; 2016 Oct; 7(41):66595-66605. PubMed ID: 27448974
[TBL] [Abstract][Full Text] [Related]
55. A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations.
Kramer D; Thunnissen FB; Gallegos-Ruiz MI; Smit EF; Postmus PE; Meijer CJ; Snijders PJ; Heideman DA
Cell Oncol; 2009; 31(3):161-7. PubMed ID: 19478384
[TBL] [Abstract][Full Text] [Related]
56. EGFR gene mutations: is it prognostic or predictive in surgically resected lung cancer?
Mitsudomi T; Tada H
J Thorac Oncol; 2012 Dec; 7(12):1739-1741. PubMed ID: 23154542
[No Abstract] [Full Text] [Related]
57. Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
Colling R; Bancroft H; Langman G; Soilleux E
Virchows Arch; 2019 Feb; 474(2):187-192. PubMed ID: 30470932
[TBL] [Abstract][Full Text] [Related]
58. The use of EGFR exon 19 and 21 unlabeled DNA probes to screen for activating mutations in non-small cell lung cancer.
Willmore-Payne C; Holden JA; Wittwer CT; Layfield LJ
J Biomol Tech; 2008 Jul; 19(3):217-24. PubMed ID: 19137110
[TBL] [Abstract][Full Text] [Related]
59. Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study.
Corrales-Rodriguez L; Soulières D; Weng X; Tehfe M; Florescu M; Blais N
Thromb Res; 2014 Jan; 133(1):48-51. PubMed ID: 24290524
[TBL] [Abstract][Full Text] [Related]
60. EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.
Ozluk Y; Firat P; Yegen G; Hocaoglu J; Tas S; Yilmazbayhan D
Cytopathology; 2017 Feb; 28(1):35-45. PubMed ID: 27389045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
